PRIMARY DRUG OF USE AMONG PERSONS TREATED FOR DRUG PROBLEMS 2017-2021 (or latest year available

Region SubRegion Country

Africa West and Central Africa Senegal
Africa West and Central Africa Senegal
Africa West and Central Africa Senegal
Africa West and Central Africa Senegal
Africa West and Central Africa Senegal
Africa West and Central Africa Senegal

Data Sources:

ARQMSC Data provided by Member States in the Annual Report Questionnaire

PrePub Data received from the Member States in the Pre- Publication process
Data received from the Drug Abuse Information Network for Asia and the Pacific
DAINAP (DAINAP)
GOV Data from Government reports
UNODC Field /Regiona
Data from UNODC Field /Regional Office
17-2021 (or latest year available)
msCode Reference.yeDrugGroup
SEN 2019 Cannabis-type drugs
SEN 2019 Opioids, including opiates and synthetic opioids
SEN 2019 Cocaine-type drugs
SEN 2019 Non-medical use of pharmaceutical sedatives and tr
SEN 2019 Solvents and inhalants
SEN 2019 Opioids, including opiates and synthetic opioids

and the Pacific

Drug value Data Source Coverage
Cannabis-type drugs 1191 ARQMSC Subnational
Heroin 183 ARQMSC Subnational
Cocaine-type drugs 96 ARQMSC Subnational
Benzodiazepines 132 ARQMSC Subnational
Solvents and inhalants 29 ARQMSC Subnational
Pharmaceutical opioids 25 ARQMSC Subnational
Campaign
HIST2019
HIST2019
HIST2019
HIST2019
HIST2019
HIST2019
Reference.ye
DrugGroup
ar
2019 Cannabis-type drugs
2019 Opioids, including opiates and synthetic opioids
2019 Cocaine-type drugs
2019 Non-medical use of pharmaceutical sedatives and tranquillizers
2019 Solvents and inhalants
2019 Opioids, including opiates and synthetic opioids
 Drug value

Cannabis-type drugs 1191

Heroin 183
Cocaine-type drugs 96
Benzodiazepines 132
Solvents and inhalants 29
Pharmaceutical opioids 25